EUVIMEDEUVIMED entdecken
Crossref

A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease

Ramya Sunkara, Jithendra Chimakurthy

Current Trends in Biotechnology and Pharmacy · 09.06.2026 · 20 (2a) · 174-189

DOI: 10.5530/ctbp.2026.2s.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Trends in Biotechnology and Pharmacy, online erschienen am 09.06.2026. Verfasst von Ramya Sunkara und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sunkara, R., & Chimakurthy, J. (2026). A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease. Current Trends in Biotechnology and Pharmacy, 20(2a), 174-189. https://doi.org/10.5530/ctbp.2026.2s.14

Vancouver

Sunkara R, Chimakurthy J. A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease. Current Trends in Biotechnology and Pharmacy. 2026;20(2a):174-189. doi:10.5530/ctbp.2026.2s.14

BibTeX
@article{Sunkara2026,
  author = {Sunkara, Ramya and Chimakurthy, Jithendra},
  title = {A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease},
  journal = {Current Trends in Biotechnology and Pharmacy},
  year = {2026},
  volume = {20},
  number = {2a},
  pages = {174--189},
  doi = {10.5530/ctbp.2026.2s.14}
}
Kostenlos starten →